» Articles » PMID: 11074002

Transforming Growth Factor Beta-independent Shuttling of Smad4 Between the Cytoplasm and Nucleus

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2000 Nov 14
PMID 11074002
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Smad4 plays a pivotal role in all transforming growth factor beta (TGF-beta) signaling pathways. Here we describe six widely expressed alternatively spliced variants of human Smad4 with deletions of different exons in the linker, the region of Smad4 that separates the two well-conserved MH1 and MH2 domains. All these Smad4 variants form complexes with activated Smad2 and Smad3 and are incorporated into DNA-binding complexes with the transcription factor Fast-1, regardless of the amount of linker they contain. However, sequences encoded by exons 5 to 7 in the linker are essential for transcriptional activation. Most importantly, our observation that different Smad4 isoforms have different subcellular localizations has led us to the identification of a functional CRM1-dependent nuclear export signal in the Smad4 linker and a constitutively active nuclear localization signal in the N-terminal MH1 domain. In the absence of TGF-beta signaling, we conclude that Smad4 is rapidly and continuously shuttling between the nucleus and the cytoplasm, the distribution of Smad4 between the nucleus and the cytoplasm being dictated by the relative strengths of the nuclear import and export signals. We demonstrate that inhibition of CRM1-mediated nuclear export by treatment of cells with leptomycin B results in endogenous Smad4 accumulating very rapidly in the nucleus. Endogenous Smad2 and Smad3 are completely unaffected by leptomycin B treatment, indicating that the nucleocytoplasmic shuttling is specific for Smad4. We propose that, upon TGF-beta signaling, complex formation between Smad4 and activated Smad2 or -3 leads to nuclear accumulation of Smad4 through inhibition of its nuclear export. We demonstrate that after prolonged TGF-beta signaling Smad2 becomes dephosphorylated and Smad2 and Smad4 accumulate back in the cytoplasm.

Citing Articles

SMAD4 Limits PARP1 dependent DNA Repair to Render Pancreatic Cancer Cells Sensitive to Radiotherapy.

Wang Y, Yu T, Zhao Z, Li X, Song Y, He Y Cell Death Dis. 2024; 15(11):818.

PMID: 39528473 PMC: 11555233. DOI: 10.1038/s41419-024-07210-7.


Bone morphogenetic protein signaling: the pathway and its regulation.

Akiyama T, Raftery L, Wharton K Genetics. 2023; 226(2).

PMID: 38124338 PMC: 10847725. DOI: 10.1093/genetics/iyad200.


Doxorubicin-induced modulation of TGF-β signaling cascade in mouse fibroblasts: insights into cardiotoxicity mechanisms.

Patricelli C, Lehmann P, Oxford J, Pu X Sci Rep. 2023; 13(1):18944.

PMID: 37919370 PMC: 10622533. DOI: 10.1038/s41598-023-46216-7.


Melatonin and TGF-β-Mediated Release of Extracellular Vesicles.

Piekarska K, Bonowicz K, Grzanka A, Jaworski L, Reiter R, Slominski A Metabolites. 2023; 13(4).

PMID: 37110233 PMC: 10142249. DOI: 10.3390/metabo13040575.


Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer.

Hurwitz E, Parajuli P, Ozkan S, Prunier C, Nguyen T, Campbell D J Cell Biol. 2023; 222(4).

PMID: 36828547 PMC: 9999015. DOI: 10.1083/jcb.202203036.


References
1.
Kaffman A, OShea E . Regulation of nuclear localization: a key to a door. Annu Rev Cell Dev Biol. 1999; 15:291-339. DOI: 10.1146/annurev.cellbio.15.1.291. View

2.
Heldin C, Ten Dijke P . SMAD destruction turns off signalling. Nat Cell Biol. 1999; 1(8):E195-7. DOI: 10.1038/70223. View

3.
de Caestecker M, Yahata T, Wang D, Parks W, Huang S, Hill C . The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem. 2000; 275(3):2115-22. DOI: 10.1074/jbc.275.3.2115. View

4.
Sotiropoulos A, Gineitis D, Copeland J, Treisman R . Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell. 1999; 98(2):159-69. DOI: 10.1016/s0092-8674(00)81011-9. View

5.
Zhu H, Kavsak P, Abdollah S, Wrana J, Thomsen G . A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 1999; 400(6745):687-93. DOI: 10.1038/23293. View